Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome for acute pain after thoracic surgery (real-world, multicenter)
ChiCTR2400094672Phase 4Not yet recruiting
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bupivacaine in postoperative pain, sponsored by Shanghai Pulmonary Hospital. Primary endpoint: Incidence of severe pain at 24 hours postoperatively. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400094672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094672.